LBRX CIK: 1691082

LB Pharmaceuticals Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY24
FY25
FY24 – FY25
(positive)
Change from FY24 to FY25
millions USD
FY24:
−53.1
FY25:
−35.2
Change from FY24 to FY25
millions USD
FY24:
23.2
FY25:
−39.9
Change from FY24 to FY25
millions USD
FY24:
38.3
FY25:
303
millions USD
FY24:
8.50
FY25:
227
(positive)
Change from FY24 to FY25
millions USD
FY24:
−53.8
FY25:
−35.3

All amounts in millions USD Data source:SEC EDGAR